Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.02 |
mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.087 | 0.02 |
mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.086 | 0.02 |
mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |